Seattle medical device firm EndoGastric Solutions closes $45M round for acid reflux treatment

This post was originally published on this site

EndoGastric Solutions, a medical technology company focused on acid reflux, has closed a $45 million financing round to grow the reach of its non-invasive treatment. The Series I round includes $30.5 million in funding that was announced last summer as well as a $14.5 million investment from Accelmed, a

contactedorg

%d bloggers like this: